Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
Creator
Sun, Feng
Li, Yang
Zhang, Wenhong
Xu, Bin
Shao, Lingyun
Ai, Jing-Wen
Zhou, Xian
Jiang, Xiangao
Shi, Jichan
Wu, Zhengxing
Ye, Xinchun
Yu, Hongying
Zhang, Haocheng
Zhang, Qiran
Source
Medline; PMC
abstract
BACKGROUND: Coronavirus disease 2019 (COVID-19) has infected more than 4 million people within 4 months. There is an urgent need to properly identify high-risk cases that are more likely to deteriorate even if they present mild diseases on admission. METHODS: A multicenter nested case-control study was conducted in four designated hospitals in China enrolling confirmed COVID-19 patients who were mild on admission. Baseline clinical characteristics were compared between patients with stable mild illness (stable mild group) and those who deteriorated from mild to severe illness (progression group). RESULTS: From Jan 17, 2020, to Feb 1, 2020, 85 confirmed COVID-19 patients were enrolled, including 16 in the progression group and 69 in the stable mild group. Compared to stable mild group (n = 69), patients in the progression group (n = 16) were more likely to be older, male, presented with dyspnea, with hypertension, and with higher levels of lactase dehydrogenase and c-reactive protein. In multivariate logistic regression analysis, advanced age (odds ratio [OR], 1.012; 95% confidence interval [CI], 1.020–1.166; P = 0.011) and the higher level of lactase dehydrogenase (OR, 1.012; 95% CI, 1.001–1.024; P = 0.038) were independently associated with exacerbation in mild COVID-19 patients. CONCLUSION: Advanced age and high LDH level are independent risk factors for exacerbation in mild COVID-19 patients. Among the mild patients, clinicians should pay more attention to the elderly patients or those with high LDH levels.
has issue date
2020-06-03
(
xsd:dateTime
)
bibo:doi
10.1186/s12916-020-01633-7
bibo:pmid
32493370
has license
cc-by
sha1sum (hex)
ad1d307ed1cd7fa0c95cf52a969d607aa7b92f81
schema:url
https://doi.org/10.1186/s12916-020-01633-7
resource representing a document's title
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
has PubMed Central identifier
PMC7268591
has PubMed identifier
32493370
schema:publication
BMC Med
resource representing a document's body
covid:ad1d307ed1cd7fa0c95cf52a969d607aa7b92f81#body_text
is
schema:about
of
named entity 'group'
named entity 'COVID-19'
named entity 'mild'
named entity 'c-reactive protein'
named entity 'progression'
named entity 'cases'
named entity 'IDENTIFY'
named entity 'RESULTS'
named entity 'ASSOCIATED WITH'
named entity 'LIKELY'
named entity 'PATIENTS'
named entity 'MILD'
named entity 'CLINICAL CHARACTERISTICS'
named entity 'COVID-19'
named entity 'HIGH-RISK'
named entity 'CONFIRMED'
named entity 'MONTHS'
named entity 'multicenter'
named entity 'diseases'
named entity 'Methods'
named entity 'mild'
named entity 'male'
named entity 'hospitals'
named entity 'mild'
named entity 'compared'
named entity 'lactase'
named entity 'lactase'
named entity 'Coronavirus disease 2019'
named entity 'clinical characteristics'
named entity 'odds ratio'
named entity '95% confidence interval'
named entity 'China'
named entity 'independently'
named entity 'COVID'
named entity 'CT scan'
named entity 'LDH'
named entity 'demographic'
named entity 'prognosis'
named entity 'septic shock'
named entity 'C-reactive protein'
named entity '95% confidence interval'
named entity 'mortality rate'
named entity 'SPSS'
named entity 'dyspnea'
named entity 'LDH'
named entity 'lungs'
named entity 'receptor'
named entity '8 days'
named entity 'diagnostic procedures'
named entity 'LDH'
named entity '4.25'
named entity 'binding receptor'
named entity 'WHO'
named entity 'cytokine'
named entity 'acute respiratory distress syndrome'
named entity 'epidemiological'
named entity 'virus'
named entity 'WHO'
named entity 'hazard ratio'
named entity 'Huashan Hospital'
named entity 'symptom'
named entity 'MERS-CoV'
named entity 'nested case-control study'
named entity 'lactase'
named entity 'logistic regression model'
named entity 'risk factors'
named entity 'virus'
named entity 'angiotensin converting enzyme 2'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software